-
CM Mohan Yadav Meets Bohra Spiritual Leader to Discuss Simhastha 2028 and Development
-
Mahayuti-backed Rajesh Patil Elected Chairman of Gokul Dairy Amidst Political Deadlock
-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
T4 Robotics Appoints Paul Hughes as Co-CEO and Announces Expansion into Unmanned Maritime Systems
-
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
-
Kalm with Kava and Pū'iwa Farms Hawai'i Bring Fresh Frozen Hawaiian Kava to Market
-
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
SNZweig Forms AEC Industry Advisory Council
-
Greene Concepts Highlights Groundwater Resources and Commercial Opportunities
-
Wash100 Award, GovCon Industry's Highest Honor, Opens Nominations for 2027 Season
-
Sterling Metals Announces Fully Allocated Private Placement of Units, Flow-Through Shares and Charity Flow-Through Units
-
Adcore Reports Third Quarter 2026 Results: Gross Margin Rises to 64%, Operating Loss Halved, Cash Up to $4.3 Million as Restructuring Takes Hold
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Zeb Nickel Commences Diamond Drilling at the Zeb Nickel Project
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
-
INEO Invited to 15th Annual ROTH Technology Conference in New York
-
Moderna to Present at Upcoming Conference in November 2026
-
Electrovaya to Participate in Upcoming Investor Conferences
-
Aston Bay Announces Pre-Feasibility Study Results and Maiden Mineral Reserve for the Storm Copper Project, Nunavut
-
Aztec Drills 70.1 Meters of 0.80 g/t AuEq (0.49 g/t Au and 16.85 g/t Ag) from Surface in TR26-54 at the Tombstone Project, Arizona
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
ParkerVision Reports Third Quarter 2026 Results
JACKSONVILLE, FL / ACCESS Newswire / November 10, 2026 / ParkerVision, Inc. (OTCQB:PRKR) ("ParkerVision" or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the nine months ended September 30, 2026.
2026 Summary and Recent Developments
- On September 30, 2026, the appellate court ruled that it did not have proper jurisdiction over the issues on the expedited appeal filed by the Company in October 2025 in ParkerVision v. Qualcomm, sending the case back to the middle district of Florida for proceedings on the transmitter patent claims only.
- Following final judgment on the transmitter-only proceedings, the Company will have an opportunity to re-appeal the district court's 2025 claim construction ruling that led to a stipulation of noninfringement of the Company's receiver patent claims.
- On August 31, 2026, working with The Oversight Project, formerly part of the Heritage Foundation, the Company filed a Freedom of Information Act ("FOIA") complaint against the National Archives and Records Administration ("NARA") to compel the production of identified documents potentially relating to our prior patent infringement case against Qualcomm. The NARA has a deadline of November 13, 2026 to respond to the complaint.
- Judge Albright, the district court judge originally assigned to all of the Company's Texas patent infringement actions, retired from the bench on August 31, 2026. The Company is awaiting reassignment of its MediaTek case and trial schedules for both MediaTek and Realtek cases.
Jeffrey Parker, CEO of ParkerVision, commented, "While we believe bifurcation of our Qualcomm case is inefficient, the appellate court's decision does not impact the merits of our case, and we are eager to pursue a jury trial on our transmitter claims as expeditiously as possible. At the appropriate time, we fully intend to pursue appellate court review of the district court's 2025 claim construction ruling with respect to our receiver claims. We are hopeful that schedules will be set soon in our MediaTek and Realtek cases which are both primed and ready for trial."
Mr. Parker continued, "We are looking forward to a response from the National Archives given that, to date, nearly a year since responsive documents have been identified, we have still not received any of the identified responsive documents to our request. It has been communicated by the Department of Justice ("DOJ") to our counsel at The Oversight Project that our FOIA case implicates communications between officials at the highest levels of government that will necessitate unusually in-depth interaction between the U.S. Attorney's Office, the DOJ and the National Archives. While we do not know what information the responsive documents may contain, the terms used in our document request were narrowly tailored to ParkerVision, and we are understandably curious as to why any communications regarding ParkerVision would exist between government officials 'at the highest levels,' according to DOJ officials, during the period in 2014 when our first Qualcomm jury verdict was overturned by the courts. We believe our shareholders deserve the answer to that question."
Financial Results
- ParkerVision reported a net loss for the nine months ended September 30, 2026 of $0.5 million, or $0.00 per common share, compared to a net loss of $7.4 million, or $0.06 per common share for the nine months ended September 30, 2025.
- The decrease in net loss is the result of a $3.0 million, or 46%, decrease in operating expenses and a $3.4 million gain as a result of a decrease in the fair value of the Company's contingent payment obligations for the nine months ended September 30, 2026, compared to a $0.5 million loss from an increase in fair value for the corresponding period in 2025.
- The decrease in operating expenses is the result of a $0.9 million reduction in outside professional fees, including third-party consulting, public relations and litigation-related costs, as well as a $2.1 million decrease in share-based compensation.
- The decrease in fair value of the contingent payment obligations is the result of changes in the estimated timing and amount of projected future cash flows due to changes in the status of our patent infringement cases, including bifurcation of the Qualcomm case, as well as increases in the risk-free rates of return used in the discount rate to calculate fair value.
- The Company used approximately $2.5 million in cash for operations for the nine months ended September 30, 2026 and ended the quarter with $1.6 million in cash and cash equivalents.
About ParkerVision
ParkerVision, Inc. invents, develops and licenses cutting-edge, proprietary radio-frequency (RF) technologies that enable wireless solution providers to make and sell advanced wireless communication products. ParkerVision is engaged in a number of patent enforcement actions in the U.S. to protect patented rights that it believes are broadly infringed by others. For more information, please visit www.parkervision.com. (PRKR-I)
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These include statements regarding the timing, scheduling, and expected outcomes of current and future legal proceedings, the Company's expectations regarding such proceedings, and expectations concerning court rulings, trial dates, and its FOIA request and related lawsuit. Forward-looking statements also include estimates and assumptions underlying financial information, including the fair value of contingent payment obligations and the Company's ability to support ongoing operations and litigation.
These statements are based on current expectations, estimates, projections, and assumptions as of the date of this release, and involve known and unknown risks and uncertainties that could cause actual results to differ materially. Words such as "believe,""intend," "hopeful," "will," and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements include these words. Risks and uncertainties that may cause actual results to differ include, among others: adverse developments or delays in legal proceedings, including changes in litigation schedules; unfavorable court decisions or rulings; the loss or unavailability of key expert witnesses; the availability of funding for continued operations and litigation; changes in the legal or regulatory environment; inaccuracies in financial estimates or assumptions; and risks disclosed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025, and subsequent filings.
Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances.
Cindy French
Chief Financial Officer
ParkerVision, Inc
[email protected]
(TABLES FOLLOW)
ParkerVision, Inc.
Balance Sheet Highlights
| (unaudited) | ||||
(in thousands) | September 30, 2026 | December 31, 2025 | ||
Cash and cash equivalents | $ | 1,642 | $ | 4,360 |
Prepaid expenses and other current assets | 523 | 304 | ||
Intangible assets & other noncurrent assets | 602 | 695 | ||
Total assets | 2,767 | 5,359 | ||
Current liabilities | 2,950 | 2,409 | ||
Contingent payment obligations | 42,708 | 46,089 | ||
Convertible notes, net of current portion | 600 | 1,908 | ||
Other long-term liabilities | - | 57 | ||
Shareholders' deficit | (43,491 | ) | (45,104 | ) |
Total liabilities and shareholders' deficit | $ | 2,767 | $ | 5,359 |
ParkerVision, Inc.
Summary Results of Operations (unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||
(in thousands, except per share amounts) | September 30, | September 30, | ||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
Licensing revenue | $ | - | $ | - | $ | - | $ | - | ||||
Cost of sales | (33 | ) | (50 | ) | (104 | ) | (156 | ) | ||||
Gross margin | (33 | ) | (50 | ) | (104 | ) | (156 | ) | ||||
Selling, general and administrative expenses | 1,086 | 1,504 | 3,558 | 6,590 | ||||||||
Total operating expenses | 1,086 | 1,504 | 3,558 | 6,590 | ||||||||
Interest expense and other | (33 | ) | (55 | ) | (221 | ) | (139 | ) | ||||
Change in fair value of contingent payment obligations | 2,055 | (357 | ) | 3,381 | (514 | ) | ||||||
Total other income (expense) | 2,022 | (412 | ) | 3,160 | (653 | ) | ||||||
Net income (loss) | $ | 903 | $ | (1,966 | ) | $ | (502 | ) | $ | (7,399 | ) | |
Earnings (loss) per common share | ||||||||||||
Basic | $ | 0.01 | $ | (0.02 | ) | $ | (0.00 | ) | $ | (0.06 | ) | |
Diluted | $ | 0.01 | $ | (0.02 | ) | $ | (0.00 | ) | $ | (0.06 | ) | |
Weighted average shares outstanding | ||||||||||||
Basic | 148,167 | 120,147 | 146,908 | 117,322 | ||||||||
Diluted | 168,512 | 120,147 | 146,908 | 117,322 | ||||||||
ParkerVision, Inc.
Summary of Cash Flows
(unaudited)
| Nine Months Ended | ||||||
(in thousands) | September 30, | |||||
| 2026 | 2025 | |||||
Net cash used in operating activities | $ | (2,548 | ) | $ | (4,071 | ) |
Net cash used in investing activities | (12 | ) | (52 | ) | ||
Net cash (used in) provided by financing activities | (158 | ) | 106 | |||
Net decrease in cash and cash equivalents | (2,718 | ) | (4,017 | ) | ||
Cash and cash equivalents - beginning of period | 4,360 | 4,918 | ||||
Cash and cash equivalents - end of period | $ | 1,642 | $ | 901 | ||
SOURCE: ParkerVision, Inc.
View the original press release on ACCESS Newswire
P.Costa--AMWN